hotspot -WSS

hotspot

author：knowledge 2025-08-07 16:18:44 - browse：38972

Photo illustration of Fyodor Urnov surrounded by DNA strands. -- health coverage from STAT — Christine Kao/STAT

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing.

Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates. “Anyone who would listen,” he says.

The problem was one of scale. Sure, for-profit companies were developing cures for a small handful of genetic diseases, such as sickle cell disease. But there were hundreds of devastating conditions that CRISPR might be able to cure but that no entity was seriously working on.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： What it’s like to watch children die of measles

hotspot

WSS

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Trump demands the U.S. pay no more for drugs than other countries … again

Precocious puberty in girls comes with mental health risks

CDC marks new Covid

United colonoscopy coverage change 'may cost lives,' doctors say

Amylyx ALS drug failure raises questions and concerns

entertainment

hotspot

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Activists slam private health insurers over coverage restrictions

New air purifier tech could be key to improving indoor air quality

RSV shot was 90% effective at preventing hospitalizations in kids

Tori Bowie and the unacceptable rates of Black maternal death

Psychedelics group wrestles with new pharma identity

Dobbs anniversary: the lost opportunity of abortion as health care

Amylyx ALS drug fails large clinical trial

Wikipedia

First medicine developed to treat MASH expected to be approved soon

23andMe had bad news about my health. I wish a person had delivered it

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

ChatGPT in medicine: STAT answers readers' burning questions

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Air quality improving but still lags in Black, Hispanic communities

hotspot

hotspot

Wikipedia

knowledge